Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Jan 2002 Balancing Parental Wishes and Medical Judgment Joal Hill, JD, MPH Virtual Mentor. 2002;-. doi: 10.1001/virtualmentor.2002.4.1.ccas1-0201. Case and Commentary Jun 2016 Medication Refusal in Schizophrenia: Preventive and Reactive Ethical Considerations James Sabin, MD Overriding a proxy decision maker’s refusal of medication for a psychotic patient is justified when the patient poses a danger to himself or others. AMA J Ethics. 2016;18(6):572-578. doi: 10.1001/journalofethics.2016.18.6.ecas1-1606. Medicine and Society Aug 2016 The Penetrating Gaze and the Decline of the Autopsy William E. Stempsey, MD, PhD Because physicians view autopsies differently than families of the deceased, informed consent rather than permission should be obtained for autopsies. AMA J Ethics. 2016;18(8):833-838. doi: 10.1001/journalofethics.2016.18.8.msoc1-1608. Letter to the Editor Jun 2023 Response to “Healthy Conversation About Meat?” Temple Grandin, PhD This letter responds to readers’ recent letter to the editor. AMA J Ethics. 2023;25(6):E464-465. doi: 10.1001/amajethics.2023.464. Case and Commentary Aug 2023 How Should Surgeons Consider Emerging Innovations in Artificial Intelligence and Robotics? Ava G. Chappell, MD and Chad M. Teven, MD This article considers which risks AI-facilitated surgical robotics pose for safety, confidentiality, informed consent, and surgical training. AMA J Ethics. 2023;25(8):E589-597. doi: 10.1001/amajethics.2023.589. Podcast Jul 2023 Author Interview: “AMA Code of Medical Ethics’ Opinions Related to Clinical Use of BMI” Dr Jake Young joins Ethics Talk to discuss his article: “AMA Code of Medical Ethics’ Opinions Related to Clinical Use of BMI.” Case and Commentary Sep 2023 Does It Matter Whether a Psychiatric Intervention Is “Palliative”? Brent M. Kious, MD, PhD and Ryan H. Nelson, PhD Uncertainty about which psychiatric interventions are palliative stems from psychiatry’s prioritization of symptom management regardless of diagnosis. AMA J Ethics. 2023;25(9):E655-660. doi: 10.1001/amajethics.2023.655. Viewpoint Sep 2023 What Should Clinicians Know About Palliative Psychopharmacology? Awais Aftab, MD This article examines conceptual limitations of extant accounts of palliative psychiatry, with a focus on obligations to distinguish among and clearly formulate goals of care. AMA J Ethics. 2023;25(9):E710-717. doi: 10.1001/amajethics.2023.710. Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725. Pagination First page « First Previous page ‹ Previous … Page 10 Page 11 Page 12 Page 13 Current page 14 Page 15 Page 16 Page 17 Page 18 … Next page Next › Last page Last »
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Jan 2002 Balancing Parental Wishes and Medical Judgment Joal Hill, JD, MPH Virtual Mentor. 2002;-. doi: 10.1001/virtualmentor.2002.4.1.ccas1-0201.
Case and Commentary Jun 2016 Medication Refusal in Schizophrenia: Preventive and Reactive Ethical Considerations James Sabin, MD Overriding a proxy decision maker’s refusal of medication for a psychotic patient is justified when the patient poses a danger to himself or others. AMA J Ethics. 2016;18(6):572-578. doi: 10.1001/journalofethics.2016.18.6.ecas1-1606.
Medicine and Society Aug 2016 The Penetrating Gaze and the Decline of the Autopsy William E. Stempsey, MD, PhD Because physicians view autopsies differently than families of the deceased, informed consent rather than permission should be obtained for autopsies. AMA J Ethics. 2016;18(8):833-838. doi: 10.1001/journalofethics.2016.18.8.msoc1-1608.
Letter to the Editor Jun 2023 Response to “Healthy Conversation About Meat?” Temple Grandin, PhD This letter responds to readers’ recent letter to the editor. AMA J Ethics. 2023;25(6):E464-465. doi: 10.1001/amajethics.2023.464.
Case and Commentary Aug 2023 How Should Surgeons Consider Emerging Innovations in Artificial Intelligence and Robotics? Ava G. Chappell, MD and Chad M. Teven, MD This article considers which risks AI-facilitated surgical robotics pose for safety, confidentiality, informed consent, and surgical training. AMA J Ethics. 2023;25(8):E589-597. doi: 10.1001/amajethics.2023.589.
Podcast Jul 2023 Author Interview: “AMA Code of Medical Ethics’ Opinions Related to Clinical Use of BMI” Dr Jake Young joins Ethics Talk to discuss his article: “AMA Code of Medical Ethics’ Opinions Related to Clinical Use of BMI.”
Case and Commentary Sep 2023 Does It Matter Whether a Psychiatric Intervention Is “Palliative”? Brent M. Kious, MD, PhD and Ryan H. Nelson, PhD Uncertainty about which psychiatric interventions are palliative stems from psychiatry’s prioritization of symptom management regardless of diagnosis. AMA J Ethics. 2023;25(9):E655-660. doi: 10.1001/amajethics.2023.655.
Viewpoint Sep 2023 What Should Clinicians Know About Palliative Psychopharmacology? Awais Aftab, MD This article examines conceptual limitations of extant accounts of palliative psychiatry, with a focus on obligations to distinguish among and clearly formulate goals of care. AMA J Ethics. 2023;25(9):E710-717. doi: 10.1001/amajethics.2023.710.
Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725.